ZEB1 and hepatocellular carcinoma: In HCC, circ_KIAA1429 (originate from KIAA1429) can accelerate the progress of HCC through the m6A-YTHDF3-Zeb1 mechanism, and may be a potential target for the HCC therapy 131.